Report #2875219

Received Nov 27, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: —
Recovered: Not recovered
Vaccinated: Nov 19, 2025
Onset: Nov 22, 2025
Days to onset: 3
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	EK225	—

Symptoms (1)

Oral herpes

Symptom narrative

cold sore on lip; This non-serious case was reported by a other health professional and described the occurrence of cold sores lip in a 85-year-old female patient who received Herpes zoster (Shingrix) (batch number EK225, expiry date 10-MAR-2027) for prophylaxis. The patient's past medical history included cold sores. Concurrent medical conditions included hypertension. Concomitant products included atorvastatin, citalopram, clopidogrel, furosemide, levetiracetam, losartan, metoprolol and pantoprazole. On 19-NOV-2025, the patient received the 1st dose of Shingrix (unknown deltoid) .5 ml. On 22-NOV-2025, 3 days after receiving Shingrix, the patient experienced cold sores lip (Verbatim: cold sore on lip). The outcome of the cold sores lip was resolving. The reporter considered the cold sores lip to be possibly related to Shingrix. The company considered the cold sores lip to be possibly related to Shingrix. Additional Information: GSK Receipt Date: 24-NOV-2025 Patient had a history of cold sore and it seemed Shingrix 1st dose triggered an episode possibly.

Current illness

Hypertension

Medical history

Medical History/Concurrent Conditions: Cold sores

Other medications

ATORVASTATIN; CITALOPRAM; CLOPIDOGREL; FUROSEMIDE; LEVETIRACETAM; LOSARTAN; METOPROLOL; PANTOPRAZOLE